ArticleFrontiers in immunology2024

Cost-effectiveness analysis of benmelstobart, anlotinib, and chemotherapy in extensive-stage small-cell lung cancer.

Maojin You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.